{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:50:58Z","timestamp":1763754658650,"version":"3.45.0"},"reference-count":20,"publisher":"Oncology Nursing Society (ONS)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"DOI":"10.1188\/25.cjon.285-290","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:19:37Z","timestamp":1755019177000},"source":"Crossref","is-referenced-by-count":0,"title":["Advancing Lymphedema Surveillance With Evidence-Based Practices"],"prefix":"10.1188","member":"1302","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Armer, J., Ostby, P.L., Ginex, P.K., Beck, M., Deng, J., Fu, M.R., . . . Morgan, R.L. (2020). ONS Guidelines\u2122 for cancer treatment\u2013related lymphedema. Oncology Nursing Forum, 47(5), 518\u2013538. https:\/\/doi.org\/10.1188\/20.ONF.518-538","DOI":"10.1188\/20.ONF.518-538"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bhimani, F., McEvoy, M., Chen, Y., Gupta, A., Pastoriza, J., Cavalli, A., . . . Feldman, S. (2024). Comprehensive strategies in breast cancer-related lymphedema prevention: Insights from a multifaceted program. Frontiers in Oncology, 14, 1418610. https:\/\/doi.org\/10.3389\/fonc.2024.1418610","DOI":"10.3389\/fonc.2024.1418610"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bowman, C., & Rockson, S.G. (2024a). The lymphedema patient experience within the healthcare system: A cross-sectional epidemiologic assessment. Scientific Reports, 14, 12600. https:\/\/doi.org\/10.1038\/s41598-024-63145-1","DOI":"10.1038\/s41598-024-63145-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bowman, C., & Rockson, S.G. (2024b). The role of inflammation in lymphedema: A narrative review of pathogenesis and opportunities for therapeutic intervention. International Journal of Molecular Sciences, 25(7), 3907. https:\/\/doi.org\/10.3390\/ijms25073907","DOI":"10.3390\/ijms25073907"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Boyages, J., Vicini, F.A., Manavi, B.A., Gaw, R.L., Koelmeyer, L.A., Ridner, S.H., & Shah, C. (2023). Axillary treatment and chronic breast cancer\u2013related lymphedema: Implications for prospective surveillance and intervention from a randomized controlled trial. JCO Oncology Practice, 19(12), 1116\u20131124. https:\/\/doi.org\/10.1200\/OP.23.00060","DOI":"10.1200\/OP.23.00060"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Brunelle, C.L., Jackson, K., Shallwani, S.M., Hunley, J.H., Kennedy, A., Fench, S., . . . Stewart, P. (2024). Evidence-based recommendations regarding risk reduction practices for people at risk of or with breast cancer-related lymphedema: Consensus from an expert panel. Medical Oncology, 41(11), 298. https:\/\/doi.org\/10.1007\/s12032-024-02510-6","DOI":"10.1007\/s12032-024-02510-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Davies, C., Levenhagen, K., Ryans, K., Perdomo, M., & Gilchrist, L. (2020). Interventions for breast cancer\u2013related lymphedema: Clinical practice guideline from the Academy of Oncologic Physical Therapy of APTA. Physical Therapy, 100(7), 1163\u20131179. https:\/\/doi.org\/10.1093\/ptj\/pzaa087","DOI":"10.1093\/ptj\/pzaa087"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Eaton, L.H., Narkthong, N., & Hulett, J.M. (2020). Psychosocial issues associated with breast cancer\u2013related lymphedema: A literature review. Current Breast Cancer Reports, 12(4), 216\u2013224. https:\/\/doi.org\/10.1007\/s12609-020-00376-x","DOI":"10.1007\/s12609-020-00376-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Executive Committee of the International Society of Lymphology. (2023). The diagnosis and treatment of peripheral lymphedema: 2023 consensus document of the International Society of Lymphology. Lymphology, 56(4), 133\u2013151.","DOI":"10.2458\/lymph.6372"},{"key":"10","unstructured":"ImpediMed. (2017, Dec. 6). ImpediMed launches FDA-cleared SOZO\u2122 system. https:\/\/www.impedimed.com\/impedimed-launches-fda-cleared-sozo-system"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Letellier, M.-E., Ibrahim, M., Towers, A., & Chaput, G. (2024). Incidence of lymphedema related to various cancers. Medical Oncology, 41(10), 245. https:\/\/doi.org\/10.1007\/s12032-024-02441-2","DOI":"10.1007\/s12032-024-02441-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"McEvoy, M.P., Gomberawalla, A., Smith, M., Boccardo, F.M., Holmes, D., Djohan, R., . . . Feldman, S. (2022). The prevention and treatment of breast cancer-related lymphedema: A review. Frontiers in Oncology, 12, 1062472. https:\/\/doi.org\/10.3389\/fonc.2022.1062472","DOI":"10.3389\/fonc.2022.1062472"},{"key":"13","unstructured":"National Comprehensive Cancer Network. (2024). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Survivorship clinical practice guidelines [v.2.2024]. https:\/\/www.nccn.org"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Rafn, B.S., Christensen, J., Larsen, A., & Bloomquist, K. (2022). Prospective surveillance for breast cancer-related arm lymphedema: A systematic review and meta-analysis. Journal of Clinical Oncology, 40(9), 1009\u20131026. https:\/\/doi.org\/10.1200\/JCO.21.01681","DOI":"10.1200\/JCO.21.01681"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ren, Y., Kebede, M.A., Ogunleye, A.A., Emerson, M.A., Evenson, K.R., Carey, L.A., . . . Troester, M.A. (2022). Burden of lymphedema in long-term breast cancer survivors by race and age. Cancer, 128(23), 4119\u20134128. https:\/\/doi.org\/10.1002\/cncr.34489","DOI":"10.1002\/cncr.34489"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Ridner, S.H., Dietrich, M.S., Boyages, J., Koelmeyer, L., Elder, E., Hughes, T.M., . . . Shah, C. (2022). A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention. Lymphatic Research and Biology, 20(6), 618\u2013628. https:\/\/doi.org\/10.1089\/lrb.2021.0084","DOI":"10.1089\/lrb.2021.0084"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Stout, N.L., Ibrahim, M., Armer, J., Vargo, M., Rodrick, J., Nourse, J., . . . Aldrich, M.B. (2024). Consensus statement on non-cancer-related risk factors for development of secondary lymphedema. Medical Oncology, 41(11), 284. https:\/\/doi.org\/10.1007\/s12032-024-02457-8","DOI":"10.1007\/s12032-024-02457-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"T\u00fcmkaya, M.N., & Seven, M. (2025). Interventions for prevention and management of gynecological cancer-related lower limb lymphedema: A systematic scoping review. Seminars in Oncology Nursing, 41(1), 151781. https:\/\/doi.org\/10.1016\/j.soncn.2024.151781","DOI":"10.1016\/j.soncn.2024.151781"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Vargo, M., Aldrich, M., Donahue, P., Iker, E., Koelmeyer, L., Crescenzi, R., & Cheville, A. (2024). Current diagnostic and quantitative techniques in the field of lymphedema management: A critical review. Medical Oncology, 41(10), 241. https:\/\/doi.org\/10.1007\/s12032-024-02472-9","DOI":"10.1007\/s12032-024-02472-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Wong, H.C.Y., Wallen, M.P., Chan, A.W., Dick, N., Bonomo, P., Bareham, M., . . . Chan, R.J. (2024). Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL): International Delphi consensus-based recommendations. EClinicalMedicine, 68, 102441. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102441","DOI":"10.1016\/j.eclinm.2024.102441"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/publications-research\/cjon\/29\/4\/advancing-lymphedema-surveillance-evidence-based-practices","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:47:38Z","timestamp":1763754458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/29\/4\/advancing-lymphedema-surveillance-evidence-based-practices"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1188\/25.cjon.285-290","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}